aid: precisedx
name: PreciseDx
description: 'PreciseDx is a New York-based AI digital pathology and oncology diagnostics
  company, founded out of the digital pathology program at Mount Sinai Health System.
  Its OncoIntelligence platform applies a patented Morphology Feature Array to
  hematoxylin and eosin (H&E) stained tissue images, combining AI-derived morphology
  features with clinicopathologic factors to produce an OncoIntelligence Score. The
  flagship test, PreciseBreast, stratifies early-stage breast cancer patients into
  high- and low-risk cohorts for disease recurrence up to 8.8 years, clinically
  validated across more than 1,600 cases, returning results in hours rather than the
  two to six weeks required for gene expression testing and at roughly 30 percent of
  the cost. PreciseDx operates CLIA-certified and CAP-accredited laboratories in New
  York City and Miami and is licensed in all 50 states. Test ordering for clinicians
  is handled through an authenticated web portal; the company publishes no public
  developer program, API documentation, or machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/precisedx/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
image: https://cdn.prod.website-files.com/67378b4f7c5e7a479024673e/6744ba2778d8a8afb2c924d1_PreciseDx-Webclip.svg
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Health
- Healthcare
- Diagnostics
- Digital Pathology
- Oncology
- Artificial Intelligence
- Machine-Learning
- Clinical Laboratory
- Precision Medicine
tags_raw:
- Company
- Health
- Healthcare
- Diagnostics
- Digital Pathology
- Oncology
- Artificial Intelligence
- Machine Learning
- Clinical Laboratory
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/precisedx-domain-security.yml
- type: Website
  url: https://www.precisedx.ai/
- type: Login
  url: https://portal.precisedx.ai/
- type: SignUp
  url: https://www.precisedx.ai/portal-signup
- type: Support
  url: https://www.precisedx.ai/contact
- type: Blog
  url: https://www.precisedx.ai/publications
- type: GitHubOrganization
  url: https://github.com/PreciseDx
- type: PrivacyPolicy
  url: https://www.precisedx.ai/privacy-policy
- type: TermsOfService
  url: https://www.precisedx.ai/terms-of-service
- type: Compliance
  url: https://www.precisedx.ai/certifications
- type: Conformance
  url: conformance/precisedx-conformance.yml
- type: LLMsTxt
  url: llms/precisedx-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: >-
    PreciseDx is a CLIA-certified clinical laboratory whose product is an ordered
    breast cancer prognostic test, not software — clinicians order PreciseBreast
    through an email-and-password web portal at portal.precisedx.ai and no
    api., docs. or developer. subdomain resolves in DNS at all.
  evidence:
  - url: https://portal.precisedx.ai/
    status: 200
  - url: https://portal.precisedx.ai/openapi.json
    status: 404
  - url: https://www.precisedx.ai/openapi.json
    status: 404
  - url: https://www.precisedx.ai/.well-known/agent-card.json
    status: 404
  - url: https://www.precisedx.ai/llms.txt
    status: 404
  - url: https://api.github.com/orgs/PreciseDx/repos
    status: 200
  checked: '2026-08-26'